In mitosis, faithful chromosome segregation is orchestrated by the dynamic interactions between the spindle microtubules (MTs) emanating from the opposite poles and the kinetochores of chromosomes. However, the precise mechanism that coordinates the coupling of kinetochore components to dynamic MTs has been a long-standing question. Microtubule (MT) associated proteins (MAPs) regulate MT nucleation, dynamics, MT-mediated transport and MT cross-linking in cells. Especially during mitosis, MAPs play an essential role not only in determining the spindle length, position and orientation but also in facilitating robust kinetochore-microtubule (kMT) attachments by linking the kinetochores to spindle MTs efficiently. MT-stability imparted by the MAPs is critical to ensure accurate chromosome segregation. This review primarily focuses on the specific function of non-motor kinetochore MAPs, their recruitment to kinetochores and their MT-binding properties. We also attempt to synthesize and strengthen our understanding of how these MAPs work in coordination with the kinetochore-bound Ndc80 complex (the key component of the MT-binding interface in metaphase and anaphase) to establish stable kMT attachments and control accurate chromosome segregation during mitosis.

Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive cognitive decline. The two cardinal neuropathological hallmarks of AD include buildup of cerebral β amyloid (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau. The current disease-modifying treatments are still not effective enough to lower the rate of cognitive decline. The paucity of early detection and disease progression biomarkers also seems to present a major obstacle to AD drug development. The current established readouts based on expression levels of amyloid beta, tau and phospho tau have shown many discrepancies in patient samples when linked to disease progression. There is an urgent need to identify diagnostic and disease progression biomarkers from blood, CSF or other biofluids that can facilitate early detection of the disease and provide pharmacodynamic readouts for new drugs being tested in clinical trials. Advances in proteomic approaches using state-of-the-art mass spectrometry, are now being increasingly applied to study AD disease mechanisms, identify drug targets and novel disease biomarkers. In this report, we describe applications of the quantitative proteomic approaches for understanding AD pathophysiology, summarize the current knowledge gained from proteomic investigations of AD and discuss development and validation of new predictive and diagnostic disease biomarkers.

Structural integrity is a crucial aspect of engineering components, particularly in the field of additive manufacturing (AM). Surface roughness is a vital parameter that significantly influences the structural integrity of additively manufactured parts. In this study, we present a comprehensive investigation into the relationship between surface roughness and structural integrity of Polyactic Acid (PLA) specimens produced through additive manufacturing. This research work focuses on the prediction of surface roughness of Additive Manufactured Polyactic Acid (PLA) specimens using eight different supervised machine learning regression-based algorithms. For the first time, Explainable AI techniques are employed to enhance the interpretability of the machine learning models. The eight algorithms used in this study are Support Vector Regression, Random Forest, XG Boost, Ada Boost, Catboost, Decision Tree, Extra Tree regressor, and Gradient Boosting regressor. The study analyzes the performance of these algorithms to predict the surface roughness of PLA specimens, while also investigating the impact of individual input parameters through Explainable AI methods. The experimental results indicate that the XG Boost algorithm outperforms the other algorithms with the highest coefficient of determination value of 0.9634. This value demonstrates that the XG Boost algorithm provides the most accurate predictions for surface roughness compared to other algorithms. The study also provides a comparative analysis of the performance of all the algorithms used in this study, along with insights derived from Explainable AI techniques.

(1) Background: Type-2 Diabetes (T2DM) is a long-term medical disorder characterized by Insulin deficiency and high blood glucose levels. Among other medication to cure T2DM, the review of the literature found that various Pyrimidine derivative act as an agonist for G-protein-coupled receptor 119 (GPR119) was proposed to control blood glucose levels by enhancing the function of pancreatic beta-cells and its mechanism of action with fewer adverse effects.; (2) Methods: In the present research work, in-silico investigations were carried out to investigate the potential of Pyrimidine analogue as an agonists to the protein target GPR119 receptor. We performed exhaustive molecular modelling and protein modelling methodologies such as homology mod-elling, molecular docking along with various drug designing tools such as 3D-QSAR and pharmacophore mapping to ascertain the design of better GPR119 agonists.; (3) Results: On the basis of in-depth computa-tional studies, we designed new pyrimidine moiety and analyzed them for GPR-119 receptor agonist and fur-ther explored the ADME properties. Designed compounds found to exhibit better predicted activities as com-pared to reference compound; (4) Conclusions: The current research on pyrimidine derivatives, using molec-ular docking, 3D-QSAR and Pharmacophore mapping demonstrated that the obtained computational model has significant properties and the designed molecules and Dataset from this model, produced antidiabetic compound against the target GPR119 i.e., compound 1S, 1Z and 1D with the docking score of −11.696, -9.314 and -8.721 respectively. The pharmacokinetics and drug-likeness studies revealed that these compounds may be the future candidate for the treatment of diabetes acting via GPR119 agonist mechanism.